Price Alert: Shares of Denali (DNLI) Trade 6.25% Higher at Midday June 23

Equities Staff  |

Today Denali Therapeutics Inc (NASDAQ: DNLI) is trading 6.25% up.

The latest price, as of 11:53:56 est, was $29.32. Denali has climbed $1.7 in trading today.

258,343 shares have been traded today.

As of the previous close, Denali has a YTD change of 38.99%. The company is set to release earnings on 2022-08-03.

For technical charts, analysis, and more on Denali visit the company profile.

About Denali Therapeutics Inc

Denali Therapeutics is a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases. Denali pursues new treatments by rigorously assessing genetically validated targets, engineering delivery across the BBB and guiding development through biomarkers that demonstrate target and pathway engagement. Denali is based in South San Francisco.

To get more information on Denali Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Denali Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?

Market Movers

Sponsored Financial Content